What They Are Saying: Broad Opposition to Pelosi ’s Radical Drug Pricing Plan

Recently, House Speaker Nancy Pelosi unveiled a radical drug pricing plan that would be thewrong approach for patients, the U.S. health care system,economy, and American innovation. An increasing number of stakeholders, experts and policymakers have also spoken out in broad opposition to the Pelosi plan. Here are some of their thoughts:

Source: The Catalyst - October 10, 2019 Category: Pharmaceuticals Authors: Tom Wilbur Tags: Research and Development Economic Impact Medicare Research and Investment Source Type: news